HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Abraxis Biosciences files complaint against SPARC in US District Court
Aug-21-2019

Abraxis Biosciences LLC has filed a complaint against Sun Pharma Advanced Research Company (SPARC) in the US District Court for the district of New Jersey. It alleged that the SPARC’s filing of New Drug Application (NDA) for Taclantis injection (Paclitaxel Injection Concentrate for Suspension) is an act of infringement of the Orange Book listed patents for Abraxane.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

  RELATED NEWS >>